-
All Resources
(choose a category)
-
All Resources
-
selected
Evidence
Evidence, advice, guidance and standards
-
Improvement
Improvement and implementation support
-
selected
Scrutiny
Assurance, scrutiny, measurement and reporting
-
-
Healthcare Area
- Blood and immune system
- Cancer
- Cardiovascular system
- Caring for older people
- Digestive system
- Ear, nose and throat
- Endocrine, nutritional and metabolic
- Eye
- Genitourinary system
- Health service organisation and delivery
- Infectious disease
- Injuries, accidents and wounds
- Mental and behavioural disorders
- Mouth and dental
- Musculoskeletal system
- Nervous system
- Obstetrics and gynaecology
- Paediatrics
- Public health
- Respiratory system
- Resource Type
- Programme
- Year
- Page 1 of 1
5 results found filtered by Evidence Remove Evidence Filter Scrutiny Remove Scrutiny Filter 2006 Remove 2006 Filter 2011 Remove 2011 Filter Cancer Remove Cancer Filter Clear Search
-
HBOT for osteoradionecrosis: evidence note 15
- Published
- 20 December 2006
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 112 Hormonal therapies for the adjuvant treatment early oestrogen-receptor-positive breast cancer
- Published
- 22 November 2006
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 101 - Docetaxel for the treatment of hormone-refractory metastatic prostate cancer
- Published
- 28 June 2006
- Cycle of Improvement
- Evidence
-
Appraisal Guidance 100 Oxaliplatin and capecitabine - adjuvant treatment of colorectal cancer
- Published
- 28 June 2006
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 93 - Colorectal cancer advanced- irinotecan, oxaliplatin and raltitrexed
- Published
- 25 January 2006
- Cycle of Improvement
- Evidence